Equity Research Analyst’s Stock Ratings: Waitr Holdings Inc. (WTRH), Phio Pharmaceuticals Corp. (PHIO)

Waitr Holdings Inc. (NASDAQ:WTRH) tinted loss of -1.49% (-0.18 points) to US$11.88. The volume of 0.18 Million shares climbed down over an trading activity of 187.31 Million shares. EPS ratio determined by looking at last 12 month figures is -0.16. Over the same time span, the stock marked US$15.06 as its best level and the lowest price reached was US$9.95. The corporation has a market cap of US$611.34 Million.

Waitr Holdings Inc. (NASDAQ:WTRH)’s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at -0.6 percent while most common profitability ratio return on investment (ROI) was 0 percent. The company’s institutional ownership is monitored at 55.7 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 1 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 0 think it is Hold. Recently, analysts have updated the overall rating to 1.5. 1 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is worth US$6.59 Million and has recently risen 0.55% to US$0.36. The latest exchange of 0.11 Million shares is below its average trading activity of 505.7 Million shares. The day began at US$0.37 but the price moved to US$0.37 at one point during the trading and finally capitulating to a session high of US$0.37. The stock tapped a 52-week high of US$6.76 while the mean 12-month price target for the shares is US$2.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 0.91, and a price to sales ratio of 32.96. For the past 5 years, the company’s revenue has grown 0%, while the company’s earnings per share has grown 60.3%. With an institutional ownership near 20.1%, it carries an earnings per share ratio of -2.54.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.